Vestibular and cochlear toxicity of aminoglycosides - A review

Acta Oto-Laryngologica

Volumn 120, Issue 8, 2000, Pages 904-911

  Nakashima, T ^a   Teranishi, M ^a   Hibi, T ^a   Kobayashi, M ^a   Umemura, M ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aminoglycosides; Cochleotoxicity; Intratympanic administration; M ni re's disease; Vestibulotoxicity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; APRAMYCIN; ASTROMICIN; BUTIROSIN; DACTIMICIN; DIBEKACIN; DIHYDROSTREPTOMYCIN; GENTAMICIN C; HABEKACIN; ISEPAMICIN; KANAMYCIN A; KANAMYCIN B; LIVIDOMYCIN; MICRONOMICIN; NEOMYCIN; NETILMICIN; PAROMOMYCIN; RIBOSTAMYCIN; SISOMICIN; STREPTOMYCIN; TOBRAMYCIN;

HEARING IMPAIRMENT; HUMAN; INNER EAR DISEASE; MENIERE DISEASE; OTOTOXICITY; PRIORITY JOURNAL; REVIEW; VERTIGO; VESTIBULAR DISORDER;

AMINOGLYCOSIDES; COCHLEA; COCHLEAR DISEASES; DNA, MITOCHONDRIAL; HUMANS; MUTATION; TISSUE DISTRIBUTION; VESTIBULAR DISEASES; VESTIBULE;

EID: 0034434859     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480050218627     Document Type: Review

References (84)

1. Gentamicin and other ototoxic antibiotics for the transtympanic treatment of Ménière's disease
2. Role of chemical labyrinthectomy in the treatment of Ménière's disease
3. Update on intratympanic gentamicin for Ménière's disease
4. Inner ear effects of topical gentamicin treatment in patients with Ménière's disease
5. Dose-related vestibular and cochlear effects of transtympanic gentamicin
6. 10 Years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of morbus Ménière's
7. Die intratympanale gentamicin-behandlung bei morbus meniere
8. Middle ear ototoxic treatment for inner ear disease
9. Delayed onset of ototoxic effects of gentamicin in treatment of Ménière's disease
10. Intratympanic gentamicin therapy for Ménière's disease placed by a tubal catheter with systemic isosorbide
11. Intratympanic injection of gentamicin for the treatment of delayed endolymphatic hydrops
12. Intratympanic therapy for Ménière's disease: Preliminary comparison of two regimens
13. Intratympanic gentamicin for treatment of intractable Ménière's disease: A preliminary report
14. Low-dose intratympanic gentamicin and the treatment of Ménière's disease: Preliminary results
15. Intratympanic gentamicin in Ménière's disease
16. Intratympanic gentamicin injection for the treatment of Ménière's disease
17. Intratympanic gentamicin for control of vertigo in Ménière's disease: Results of therapy
18. Round-window microcatheter-administered microdose gentamicin: Results from treatment of tinnitus associated with Ménière's disease
19. Use of a new device, the MicroWick, to deliver to the inner ear
20. Round window gentamicin mu-catheter - A new therapeutic tool in Ménière's disease
21. Inner ear perfusion and the role of round window patency
22. Direct round window membrane application of gentamicin in the treatment of Ménière's disease
23. Pharmacologic labyrinthectomy
24. The patas monkey as a model for dihydrostreptomycin ototoxicity
25. Ototoxic antibiotics: A review
26. Aminoglycosides: Activity and resistance (minireview)
27. In vitro prediction of aminoglycoside ototoxicity
28. Interaction of aminoglycoside antibiotics with phospholipid liposomes studied by microelectrophoresis
29. Aminoglycoside-induced hearing loss: A molecular hypothesis
30. Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides
31. Organ culture of late embryonic inner ear as a model for ototoxicity studies
32. Aspects on the ototoxic potential of netilmicin
33. Antibiotics and sensorineural interactions. In vitro studies
34. An in vitro rapid evaluation of drug-induced ototoxicity and of reductive effect of calcium on aminoglycoside ototoxicity using organ culture
35. Ototoxicity
36. Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics
37. The ototoxic effects of gentamicin on the vestibular maculae in pigmented guinea pigs
38. The comparative ototoxicities of gentamicin, tobramycin and dibekacin in the guinea pig. A functional and morphological cochlear and vestibular study
39. Ototoxicity
40. Relationships between ototoxicities and chemical structures of ototoxic drugs
41. Effects of different dosing regimens on aminoglycoside ototoxicity in guinea pigs
42. Aminoglycoside-induced ototoxicity
43. Action of streptomycin, dihdrostreptomycin, neomycin and kanamycin on the ampullar receptors of the frog
44. The kinetics of streptomycin, kanamycin, and neomycin in the inner ear
45. A study of the relative concentrations of antibiotics in the blood, spinal fluid and perilymph in animals
46. Experimental study on the transfer of kanamycin to the inner ear fluids
47. Inner ear concentration and ototoxicity of different antibiotics in local and systemic application
48. Pharmacokinetics and ototoxicity of gentamicin, tobramycin and amikacin
49. Kinetics of gentamicin in cochlear hair cells after chronic treatment
50. Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates
51. Distribution of gentamicin by immunofluorescence in the guinea pig inner ear
52. Uptake of amikacin by hair cells of the guinea pig cochlea and vestibule and ototoxicity: Comparison with gentamicin
53. Localization of triphosphoinositide in the cochlea. An electronmicroscopic immunocytochemical study
54. Immunocytochemical detection of triphosphoinositide in the vestibular hair cells
55. Alcian blue staining of cochlear hair cell stereocilia and other cochlear tissues
56. Anionic sites of charge barrier in the guinea pig crista ampullaris
57. Anionic sites in blood capillaries of the mouse cochlear duct
58. Effect of cisplatin on the negative charge barrier in strial vessels of the guinea pig. A transmission electron microscopic study using polyethyleneimine molecules
59. Influence of chronic administration on basement membrane anionic sites in the labyrinth
60. Cochlear blood flow after gentamicin induced damage to organ of Corti
61. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs
62. Biochemical basis of aminoglycoside ototoxicity
63. Aminogycoside antibiotics
64. Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule
65. Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and tissues and their relationship to ototoxicity
66. Protective effect of fosfomycin against aminoglycoside ototoxicity
67. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo
68. Glutathione protection against ototoxicity depends on nutritional status
69. Attenuation of aminoglycoside ototoxicity by glutathione
70. Differential cellular distribution of glutathione - An endogenous antioxidant - In the guinea pig inner ear
71. Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig
72. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo
73. Free radicals in the guinea pig inner ear following gentamicin exposure
74. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to our hair cells of a gentamicin metabolite in vitro
75. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant a-lipoic acid
76. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo
77. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity
78. Attenuation of neomycin ototoxicity by iron chelation
79. The protective effect of brain-derived neurotrophic factor after gentamicin ototoxicity
80. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss
81. Biochemical characterization of a pedigree with mitochondrially inherited deafness
82. Familial streptomycin ototoxicity in a South African family: A mitochondrial disorder
83. Accumulation sites of kanamycin in cochlear basal membrane cells
84. Oxidant mechanisms in gentamicin nephrotoxicity